Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Adequacy of family history taking in ovarian cancer patients: a population-based study.

van Altena AM, van Aarle S, Kiemeney LA, Hoogerbrugge N, Massuger LF, de Hullu JA.

Fam Cancer. 2012 Sep;11(3):343-9. doi: 10.1007/s10689-012-9518-6.

2.

Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.

Hughes KS, Roche C, Campbell CT, Siegel N, Salisbury L, Chekos A, Katz MS, Edell E.

Breast J. 2003 Jan-Feb;9(1):19-25.

PMID:
12558666
4.

The prevalence of hereditary breast/ovarian cancer risk in patients with a history of breast or ovarian cancer in Japanese subjects.

Komata D, Yahata T, Kodama S, Koyama Y, Takeda N, Tajima K, Makino H, Sato N, Muto I, Hatakeyama K, Tanaka K.

J Obstet Gynaecol Res. 2009 Oct;35(5):912-7. doi: 10.1111/j.1447-0756.2009.01090.x.

PMID:
20149041
5.
6.

Accuracy of family cancer history in breast cancer patients.

Theis B, Boyd N, Lockwood G, Tritchler D.

Eur J Cancer Prev. 1994 Jul;3(4):321-7.

PMID:
7950886
7.

A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer risk.

Vogel TJ, Stoops K, Bennett RL, Miller M, Swisher EM.

Gynecol Oncol. 2012 Jun;125(3):693-8. doi: 10.1016/j.ygyno.2012.03.025. Epub 2012 Mar 21.

PMID:
22446623
8.

Family history of breast, ovarian and endometrial cancer and risk of breast cancer.

Parazzini F, La Vecchia C, Negri E, Franceschi S, Tozzi L.

Int J Epidemiol. 1993 Aug;22(4):614-8.

PMID:
8225733
9.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
10.

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E.

J Natl Cancer Inst. 1997 Feb 5;89(3):227-38.

PMID:
9017003
11.

Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands.

van Altena AM, Karim-Kos HE, de Vries E, Kruitwagen RF, Massuger LF, Kiemeney LA.

Gynecol Oncol. 2012 Jun;125(3):649-54. doi: 10.1016/j.ygyno.2012.02.033. Epub 2012 Feb 24.

PMID:
22370602
13.

The effectiveness of family history questionnaires in cancer genetic counseling.

Armel SR, McCuaig J, Finch A, Demsky R, Panzarella T, Murphy J, Rosen B.

J Genet Couns. 2009 Aug;18(4):366-78. doi: 10.1007/s10897-009-9228-x. Epub 2009 May 21.

PMID:
19459037
14.

Hereditary breast-ovarian cancer: clinical findings and medical management.

Marshall M, Solomon S.

Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. Review.

PMID:
17901820
15.

Advances in the management of epithelial ovarian cancer.

Berkenblit A, Cannistra SA.

J Reprod Med. 2005 Jun;50(6):426-38. Review.

PMID:
16050567
16.

[Clinical characteristics of borderline ovarian tumors and stage I epithelial ovarian cancer: an analysis of 143 cases].

Zhao Y, Wang Y, Shen Dh, Song Rn, Xu Q, Li Y, Cui H, Tang J, Wei Lh.

Beijing Da Xue Xue Bao. 2011 Feb 18;43(1):123-8. Chinese.

17.

Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.

Karam AK, Stempel M, Barakat RR, Morrow M, Gemignani ML.

Gynecol Oncol. 2009 Mar;112(3):490-5. doi: 10.1016/j.ygyno.2008.11.006. Epub 2008 Dec 20.

PMID:
19101713
18.

No supportive evidence for clinical benefit of routine follow-up in ovarian cancer: a Dutch multicenter study.

Geurts SM, van Altena AM, de Vegt F, Tjan-Heijnen VC, Massuger LF, van Dijck JA, Verbeek AL.

Int J Gynecol Cancer. 2011 May;21(4):647-53. doi: 10.1097/IGC.0b013e318212b87d.

PMID:
21543930
19.

Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?

Eerola H, Blomqvist C, Pukkala E, Pyrhönen S, Nevanlinna H.

Eur J Cancer. 2000 Jun;36(9):1143-8.

PMID:
10854948
20.

Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.

Vernooij F, Heintz AP, Witteveen PO, van der Heiden-van der Loo M, Coebergh JW, van der Graaf Y.

J Natl Cancer Inst. 2008 Mar 19;100(6):399-406. doi: 10.1093/jnci/djn033. Epub 2008 Mar 11.

PMID:
18334710

Supplemental Content

Support Center